• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Santen Pharmaceutical Co Ltd

+ Add to Watchlist

SNPHY:US

29.5650 USD 0.1960 0.66%

As of 09:47:47 ET on 07/30/2014.

Snapshot for Santen Pharmaceutical Co Ltd (SNPHY)

Open: 29.5700 Day's Range: 29.5650 - 29.5700 Volume: 385
Previous Close: 29.7610 52wk Range: 20.3900 - 29.9700 1-Yr Rtn: +33.58%

Stock Chart for SNPHY

No chart data available.
  • SNPHY:US 29.5650
  • 1D
  • 1M
  • 1Y
29.7610
Interactive SNPHY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNPHY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 4,883.42
Shares Outstanding (M) 165.18
30 Day Average Volume 2,927
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.66%
Cash Dividend (USD) 0.1930
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNPHY

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for SNPHY

SANTEN PHARMACEUTICAL CO., LTD. produces and sells ophthalmic medicine. The Company manufactures a variety of products including eye drops and ointments. Santen Pharmaceutical also imports lenses and tools and equipment used by optometrists and produces anti-rheumatic drugs.

Akira KurokawaPresident/CEOSadatoshi FurukadoSenior Managing Exec Officer
Masamichi SatoManaging Executive OfficerJyrki LiljeroosExecutive Officer
More Company Profile & Key Executives for SNPHY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil